
Dermatology
Latest News
Latest Videos

CME Content
More News

How new agents, improved study outcomes, and priority on diagnosis has bettered the state of dermatologic care.

From immunotherapy to biologics, the field of allergy pharmacotherapy is looking promising.

How can physicians and specialists navigate testing options and potential risk factors to ensure patients are diagnosed and treated expediently and accurately?

There has been significant changes in understanding surrounding food allergy testing. What do parents need to know?









The Allergenic Products Advisory Committee voted in favor Friday to support the BLA data for what could become the first drug indicated for food allergy desensitization.

The approval for interstitial lung disease associated with systemic sclerosis or scleroderma makes nintedanib the first therapy for the rare condition.

The epicutaneous immunotherapy patch BLA was previously submitted to the FDA last year, but withdrawn due to concerns over manufacturing procedure and quality control.

New phase 3 data will evidence an FDA application for the biologic as an add-on therapy for patients aged 6-11 years with AD.

A new cohort shows FLG loss-of-function variations are often different among AD pediatric patients with different ancestries.

After a decade-plus, the risk management reduction program is not associated with a direct drop in at-risk pregnancies.

A recent study examined the relationship between different types of infection and incidence of stroke.

After showing the ability to regain patients' senses of smell and taste in a pair of phase 3 trials, the biologic becomes the first indicated for CRSwNP.

Both brick-and-mortar dermatology clinics as well as telehealth programs are limited and restricted by barriers to access.

Patients on 2 different doses of the once-daily oral JAK1 inhibitor reached statistically significant measures for improved symptoms.

Patients diagnosed with psoriasis face a nearly three-fold greater risk of developing anxiety disorders.

Both parents and children with atopic dermatitis often lack answers when it comes to the possibility that food allergies might be causing their skin irritations.

Marketed sunscreen in the US is a bit more regulated than in other countries. But are those regulations helpful?
















































































